InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OMX | Ann: Appendix 4G and Corporate Governance Statement | 19/09/24 | 0 | 1 | |||
|
|||||||
OMX | Ann: Annual Report to shareholders | 19/09/24 | 0 | 1 | |||
|
|||||||
OMX | Ann: Entitlement Offer Closes | 06/11/12 | 0 | 330 | |||
|
|||||||
OMX | Ann: September Quarter Activities Report | 01/11/12 | 0 | 280 | |||
|
|||||||
OMX | Ann: September Quarter Appendix 5B | 01/11/12 | 0 | 273 | |||
|
|||||||
OMX | Ann: Noitce of Annual General Meeting | 31/10/12 | 0 | 300 | |||
|
|||||||
OMX | Ann: Annual Report to shareholders | 29/10/12 | 0 | 263 | |||
|
|||||||
OMX | Ann: Notice of Annual General Meeting | 29/10/12 | 0 | 311 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||